Ddctp → 2',3'-Dideoxyuridine-5'-triphosphate
반응식
[P:1]([O:13][CH2:14][C@H:15]1[O:19][C@@H:18]([N:20]2[CH:27]=[CH:26][C:24](N)=[N:23][C:21]2=[O:22])[CH2:17][CH2:16]1)([O:4][P:5]([O:8][P:9]([OH:12])([OH:11])=[O:10])([OH:7])=[O:6])(=[O:3])[OH:2].N([O-])=[O:29].[Na+].C(O)(=O)C>>[P:1]([O:13][CH2:14][C@H:15]1[O:19][C@@H:18]([N:20]2[CH:27]=[CH:26][C:24](=[O:29])[NH:23][C:21]2=[O:22])[CH2:17][CH2:16]1)([O:4][P:5]([O:8][P:9]([OH:11])([OH:12])=[O:10])([OH:7])=[O:6])(=[O:3])[OH:2]참가 물질
3
실험 절차
The derivative was synthesized via the unstable diazonium derivative starting with the commercially available 2′,3′-dideoxy-cytidine-5′-triphosphate (Boehringer Mannheim) by deamination with NaNO2/acetic acid.
출처 및 근거
- ORD 기록
- ord-810df20c1e8148f297e8f84737b4c819
- 출처 데이터셋
- uspto-grants-2003_06
- 특허 번호
- US06573374B1
반응 노트
불러오는 중…